An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials

Authors: Sedano, Rocio, Ma, Christopher, Pai, Rish K., D' Haens, Geert, Guizzetti, Leonardo, Shackelton, Lisa M., Remillard, Julie, Gionchetti, Paolo, Gordon, Ilyssa O., Holubar, Stefan, Kayal, Maia, Lauwers, Gregory Y., Pai, Reetesh K., Pardi, Darrell S., Samaan, Mark A., Schaeffer, David F., Shen, Bo, Silverberg, Mark S., Feagan, Brian G., Sandborn, William J., Jairath, Vipul

Source: Alimentary pharmacology & therapeutics. 53(10):1108-1117

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120008314.0x000001&indx=1&recIds=ETOCvdc_100120008314.0x000001

Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood Samples

Authors: Berends, Sophie E., Bloem, Karien, de Vries, Annick, Schaap, Tiny, Rispens, Theo, Strik, Anne S., Talwar, Rawina, Löwenberg, Mark, D Haens, Geert R., Mathôt, Ron A.

Source: Therapeutic drug monitoring. 42(2):289-294

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN624694750&indx=1&recIds=ETOCRN624694750

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+T Cells in Crohn's Disease: Report of the TOSCA Study

Authors: D Haens, Geert, Vermeire, Séverine, Vogelsang, Harald, Allez, Matthieu, Desreumaux, Pierre, Van Gossum, Andre, Sandborn, William J., Baumgart, Daniel C., Ransohoff, Richard M., Comer, Gail M.

Source: Journal of Crohn's and colitis. 12(2):188-196

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN620512458&indx=1&recIds=ETOCRN620512458

The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?

Authors: Hindryckx, Pieter, Vande Casteele, Niels, Novak, Gregor, Khanna, Reena, D Haens, Geert, Sandborn, William J., Danese, Silvio, Jairath, Vipul, Feagan, Brian G.

Source: Journal of Crohn's and colitis. 12(1):105-119

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN620512343&indx=1&recIds=ETOCRN620512343

Explaining Interpatient Variability in Adalimumab Pharmacokinetics in Patients With Crohn's Disease

Authors: Berends, Sophie E., Strik, Anne S., Van Selm, Juliet C., Löwenberg, Mark, Ponsioen, Cyriel Y., D Haens, Geert R., Mathôt, Ron A.

Source: Therapeutic drug monitoring. 40(2):202-211

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN615542464&indx=1&recIds=ETOCRN615542464

Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy

Authors: D Haens, Geert, Reinisch, Walter, Colombel, Jean-Frederic, Panes, Julian, Ghosh, Subrata, Prantera, Cosimo, Lindgren, Stefan, Hommes, Daniel W., Huang, Zhiping, Boice, Judith

Source: Journal of Crohn's and colitis. 11(6):680-689

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN620511248&indx=1&recIds=ETOCRN620511248

Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial

Authors: Reinisch, Walter, Colombel, Jean-Frédéric, D Haens, Geert, Sandborn, William J., Rutgeerts, Paul, Geboes, Karel, Petersson, Joel, Eichner, Samantha, Zhou, Qian, Robinson, Anne M.

Source: Journal of Crohn's and colitis. 11(4):425-434

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN620511119&indx=1&recIds=ETOCRN620511119

Long-term Efficacy of Vedolizumab for Crohn's Disease

Authors: Vermeire, Severine, Loftus, Edward V., Colombel, Jean-Frédéric, Feagan, Brian G., Sandborn, William J., Sands, Bruce E., Danese, Silvio, D Haens, Geert R., Kaser, Arthur, Panaccione, Remo

Source: Journal of Crohn's and colitis. 11(4):412-424

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN620511102&indx=1&recIds=ETOCRN620511102

Long-term Efficacy of Vedolizumab for Ulcerative Colitis

Authors: Loftus, Edward V., Colombel, Jean-Frédéric, Feagan, Brian G., Vermeire, Severine, Sandborn, William J., Sands, Bruce E., Danese, Silvio, D Haens, Geert R., Kaser, Arthur, Panaccione, Remo

Source: Journal of Crohn's and colitis. 11(4):400-411

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN620511090&indx=1&recIds=ETOCRN620511090

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease.

Authors: Baert, Filip, Noman, Maja, Vermeire, Severine, Van Assche, Gert, D' Haens, Geert, Carbonez, An, Rutgeerts, Paul

Source: New England Journal of Medicine. 2/13/2003, Vol. 348 Issue 7, p601-608. 1p.

Subjects: CROHN'S disease, IMMUNOGLOBULINS, DISEASE risk factors, MEDICAL research